BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang H, Wang Y, Xiao Z, Li W, Dimitrov DS, Chen W. Human Domain Antibodies to Conserved Epitopes on HER2 Potently Inhibit Growth of HER2-Overexpressing Human Breast Cancer Cells In Vitro. Antibodies (Basel) 2019;8:E25. [PMID: 31544831 DOI: 10.3390/antib8010025] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu YP, Zheng CC, Huang YN, He ML, Xu WW, Li B. Molecular mechanisms of chemo- and radiotherapy resistance and the potential implications for cancer treatment. MedComm (2020) 2021;2:315-40. [PMID: 34766149 DOI: 10.1002/mco2.55] [Cited by in Crossref: 1] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
2 Yan Y, Cheng X, Li L, Zhang R, Zhu Y, Wu Z, Ding K. A Novel Small Molecular Antibody, HER2-Nanobody, Inhibits Tumor Proliferation in HER2-Positive Breast Cancer Cells In Vitro and In Vivo. Front Oncol 2021;11:669393. [PMID: 34055637 DOI: 10.3389/fonc.2021.669393] [Reference Citation Analysis]
3 Yalikong A, Li XQ, Zhou PH, Qi ZP, Li B, Cai SL, Zhong YS. A Triptolide Loaded HER2-Targeted Nano-Drug Delivery System Significantly Suppressed the Proliferation of HER2-Positive and BRAF Mutant Colon Cancer. Int J Nanomedicine 2021;16:2323-35. [PMID: 33776436 DOI: 10.2147/IJN.S287732] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Chen T, Liu X, Hong H, Wei H. Novel single-domain antibodies against the EGFR domain III epitope exhibit the anti-tumor effect. J Transl Med 2020;18:376. [PMID: 33023595 DOI: 10.1186/s12967-020-02538-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Yan Y, Xu J, Mao G. Honokiol Suppression of Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Gastric Cancer Cell Biological Activity and Its Mechanism. Med Sci Monit 2020;26:e923962. [PMID: 32862190 DOI: 10.12659/MSM.923962] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Yang EY, Shah K. Nanobodies: Next Generation of Cancer Diagnostics and Therapeutics. Front Oncol 2020;10:1182. [PMID: 32793488 DOI: 10.3389/fonc.2020.01182] [Cited by in Crossref: 31] [Cited by in F6Publishing: 56] [Article Influence: 15.5] [Reference Citation Analysis]
7 Puttemans J, Dekempeneer Y, Eersels JL, Hanssens H, Debie P, Keyaerts M, Windhorst AD, van der Aa F, Lecocq Q, Breckpot K, Morgenstern A, Bruchertseifer F, Lahoutte T, Devoogdt N, D'Huyvetter M. Preclinical Targeted α- and β--Radionuclide Therapy in HER2-Positive Brain Metastasis Using Camelid Single-Domain Antibodies. Cancers (Basel) 2020;12:E1017. [PMID: 32326199 DOI: 10.3390/cancers12041017] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 11.0] [Reference Citation Analysis]